Polyclonal Rabbit anti‑Human CASP5 / Caspase 5 Antibody (290‑370 aa, C‑terminal, WB) LS‑C380468
Polyclonal Rabbit anti‑Human CASP5 / Caspase 5 Antibody (290‑370 aa, C‑terminal, WB) LS‑C380468
Antibody:
CASP5 / Caspase 5 Rabbit anti-Human Polyclonal (290-370 aa, C-terminal) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
CASP5 / Caspase 5 Rabbit anti-Human Polyclonal (290-370 aa, C-terminal) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
Caspase 5 antibody LS-C380468 is an unconjugated rabbit polyclonal antibody to human Caspase 5 (CASP5) (290-370 aa, C-terminal). Validated for ELISA and WB.
Target
Human CASP5 / Caspase 5
Synonyms
CASP5 | CASP-5 | Caspase 5 | Caspase-5 | ICE(rel)III | ICEREL-III | ICE(rel)-III | Ich-3 | Protease TY | ICH3 | Protease ICH-3 | TY protease
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human Caspase-5 p10
Epitope
290-370 aa, C-terminal
Specificity
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody detects endogenous levels of fragment of activated Caspase-5 p10 protein resulting from cleavage adjacent to S331.
Applications
- Western blot (1:500 - 1:2000)
- ELISA (1:20000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
Western blot
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
78.125-5000 pg/ml
Source:
E. coli
Tag:
His, N-Terminal
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024